Annual Drug Patent Expirations for DALVANCE
Dalvance is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has fifty-six patent family members in twenty countries.
The generic ingredient in DALVANCE is dalbavancin hydrochloride. One supplier is listed for this compound. Additional details are available on the dalbavancin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for Allergan drug DALVANCE